Raymond James & Associates’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,456
| Closed | -$515K | – | 3915 |
|
|
2024
Q1 | $515K | Buy |
+7,456
| New | +$515K | ﹤0.01% | 3030 |
|
|
2020
Q1 | – | Sell |
-3,930
| Closed | -$242K | – | 3402 |
|
|
2019
Q4 | $242K | Sell |
3,930
-833
| -17% | -$51.3K | ﹤0.01% | 3203 |
|
|
2019
Q3 | $347K | Sell |
4,763
-124
| -3% | -$9.03K | ﹤0.01% | 2902 |
|
|
2019
Q2 | $402K | Sell |
4,887
-425
| -8% | -$35K | ﹤0.01% | 2809 |
|
|
2019
Q1 | $375K | Sell |
5,312
-9,591
| -64% | -$677K | ﹤0.01% | 2841 |
|
|
2018
Q4 | $671K | Buy |
14,903
+2,998
| +25% | +$135K | ﹤0.01% | 2338 |
|
|
2018
Q3 | $673K | Buy |
11,905
+1,450
| +14% | +$82K | ﹤0.01% | 2490 |
|
|
2018
Q2 | $698K | Sell |
10,455
-3,965
| -27% | -$265K | ﹤0.01% | 2446 |
|
|
2018
Q1 | $840K | Sell |
14,420
-7,042
| -33% | -$410K | ﹤0.01% | 2257 |
|
|
2017
Q4 | $1.38M | Sell |
21,462
-1,528
| -7% | -$98.5K | ﹤0.01% | 1934 |
|
|
2017
Q3 | $1.21M | Buy |
22,990
+17,976
| +359% | +$944K | ﹤0.01% | 1983 |
|
|
2017
Q2 | $235K | Sell |
5,014
-354
| -7% | -$16.6K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $266K | Buy |
5,368
+92
| +2% | +$4.56K | ﹤0.01% | 2753 |
|
|
2016
Q4 | $320K | Buy |
5,276
+280
| +6% | +$17K | ﹤0.01% | 2578 |
|
|
2016
Q3 | $331K | Buy |
+4,996
| New | +$331K | ﹤0.01% | 2542 |
|